Teratoma epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 8: | Line 8: | ||
===Incidence=== | ===Incidence=== | ||
*The incidence of mature teratoma is approximately 1.2-14.2 cases per 100,000 individuals worldwide.<ref name="pmid3166898">{{cite journal| author=Westhoff C, Pike M, Vessey M| title=Benign ovarian teratomas: a population-based case-control study. | journal=Br J Cancer | year= 1988 | volume= 58 | issue= 1 | pages= 93-8 | pmid=3166898 | doi=10.1038/bjc.1988.171 | pmc=2246492 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3166898 }} </ref> | *The incidence of mature teratoma is approximately 1.2-14.2 cases per 100,000 individuals worldwide.<ref name="pmid3166898">{{cite journal| author=Westhoff C, Pike M, Vessey M| title=Benign ovarian teratomas: a population-based case-control study. | journal=Br J Cancer | year= 1988 | volume= 58 | issue= 1 | pages= 93-8 | pmid=3166898 | doi=10.1038/bjc.1988.171 | pmc=2246492 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3166898 }} </ref> | ||
===Prevalence=== | ===Prevalence=== | ||
*The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide. | *The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide. | ||
*The prevalence of [disease/malignancy] is estimated to be [number] cases annually. | *The prevalence of [disease/malignancy] is estimated to be [number] cases annually. | ||
| Line 20: | Line 18: | ||
===Age=== | ===Age=== | ||
* | *Immature is mostly seen in younger patients and postpubertal males.<ref name="pmid30256256">{{cite journal| author=Kao CS, Bangs CD, Aldrete G, Cherry AM, Ulbright TM| title=A Clinicopathologic and Molecular Analysis of 34 Mediastinal Germ Cell Tumors Suggesting Different Modes of Teratoma Development. | journal=Am J Surg Pathol | year= 2018 | volume= 42 | issue= 12 | pages= 1662-1673 | pmid=30256256 | doi=10.1097/PAS.0000000000001164 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30256256 }} </ref><ref name="OutwaterSiegelman2001">{{cite journal|last1=Outwater|first1=Eric K.|last2=Siegelman|first2=Evan S.|last3=Hunt|first3=Jennifer L.|title=Ovarian Teratomas: Tumor Types and Imaging Characteristics|journal=RadioGraphics|volume=21|issue=2|year=2001|pages=475–490|issn=0271-5333|doi=10.1148/radiographics.21.2.g01mr09475}}</ref> | ||
*Mature teratoma commonly affects aldolescent, but it occurs in all age groups.<ref name="pmid30256256">{{cite journal| author=Kao CS, Bangs CD, Aldrete G, Cherry AM, Ulbright TM| title=A Clinicopathologic and Molecular Analysis of 34 Mediastinal Germ Cell Tumors Suggesting Different Modes of Teratoma Development. | journal=Am J Surg Pathol | year= 2018 | volume= 42 | issue= 12 | pages= 1662-1673 | pmid=30256256 | doi=10.1097/PAS.0000000000001164 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30256256 }} </ref> | |||
* | |||
===Race=== | ===Race=== | ||
Latest revision as of 17:48, 18 November 2019
|
Teratoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Teratoma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Teratoma epidemiology and demographics |
|
Risk calculators and risk factors for Teratoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Gertrude Djouka, M.D.[2]
Overview
Epidemiology and Demographics
Incidence
- The incidence of mature teratoma is approximately 1.2-14.2 cases per 100,000 individuals worldwide.[1]
Prevalence
- The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
- The prevalence of [disease/malignancy] is estimated to be [number] cases annually.
Case-fatality rate/Mortality rate
- In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
- The case-fatality rate/mortality rate of [disease name] is approximately [number range].
Age
- Immature is mostly seen in younger patients and postpubertal males.[2][3]
- Mature teratoma commonly affects aldolescent, but it occurs in all age groups.[2]
Race
- There is no racial predilection to [disease name].
- [Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
Gender
- [Disease name] affects men and women equally.
- [Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.
Region
- The majority of [disease name] cases are reported in [geographical region].
- [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
Developed Countries
Developing Countries
References
- ↑ Westhoff C, Pike M, Vessey M (1988). "Benign ovarian teratomas: a population-based case-control study". Br J Cancer. 58 (1): 93–8. doi:10.1038/bjc.1988.171. PMC 2246492. PMID 3166898.
- ↑ 2.0 2.1 Kao CS, Bangs CD, Aldrete G, Cherry AM, Ulbright TM (2018). "A Clinicopathologic and Molecular Analysis of 34 Mediastinal Germ Cell Tumors Suggesting Different Modes of Teratoma Development". Am J Surg Pathol. 42 (12): 1662–1673. doi:10.1097/PAS.0000000000001164. PMID 30256256.
- ↑ Outwater, Eric K.; Siegelman, Evan S.; Hunt, Jennifer L. (2001). "Ovarian Teratomas: Tumor Types and Imaging Characteristics". RadioGraphics. 21 (2): 475–490. doi:10.1148/radiographics.21.2.g01mr09475. ISSN 0271-5333.